Please login to the form below
Novartis weathers the COVID-19 storm in Q3, lifts outlook
Core operating income increased by 11%, profits from net income drop
Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue
Bamlanivimab is being studied in a number of additional ongoing trials
Bayer pays an initial $2bn for gene therapy firm AskBio
Acquisition will expand Bayers’s pipeline with preclinical/clinical candidates
Researchers say COVID-19 antibody levels have fallen rapidly in the UK
Number of people testing positive for antibodies fell by 26.5% between June and September
Both AZ and J&J set to resume US COVID-19 vaccine trials
Both companies paused their trials after separate participant illness events
PMHub Videos and Podcasts
<>- Visual Storytelling in HealthTech
- Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Roles of Neuroscience & AI in Solving Complex Healthcare Challenges
- Harnessing Technology to Improve Health and Healthcare
- Telemedicine and the Digitization of Medicine post COVID-19
- Medical Modeling in Virtual Reality
The Gallery
<>A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
Agency:
Life Healthcare CommunicationsProduct:
Self PromotionClient:
Self PromotionTherapy area:
Self Promotion
Bombarded with information – the challenge of crowded digital channels
Chris Ross explores the pursuit of communications excellence in a world of noise
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm
Perlmutter is set to join the board of AI drug discovery biotech Insitro
Preparing for online interviews and remote working
As the world changes to social distancing, here are some pointers for employees to think about
COVID-19 Updates and Daily News
Featured jobs
- Moderna completes enrolment of phase 3 COVID-19 vaccine trial
- Novartis’ MS therapy Mayzent approved by NICE
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- The Truth about Doctors
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
- Novartis weathers the COVID-19 storm in Q3, lifts outlook
- Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue
- Researchers say COVID-19 antibody levels have fallen rapidly in the UK
- Exploring the potential of eosinophils
- Eliminating pharmaceutical rebates, is this déjà vu?
- Bayer pays an initial $2bn for gene therapy firm AskBio
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....Latest intelligence
- Exploring the potential of eosinophils
- GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
- Eliminating pharmaceutical rebates, is this déjà vu?
- By Andrew Parece and Matthew Majewski...
- Patients are ready to embrace decentralised clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Quick links
Infographics
